Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Nov 30, 2025 | (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.26%883.58M | 38.93%3.49B | 6.70%889.62M | 30.36%830.25M | 60.57%883.65M | 79.53%885.89M | 11.39%2.51B | 75.13%833.74M | 20.03%636.88M | -10.95%550.33M |
| Cost of revenue | 33.23%3B | 2.56%2.25B | ||||||||
| Gross profit | 87.27%496.88M | 312.50%265.32M | ||||||||
| Operating expense | -3.19%840.48M | 3.65%474.81M | 2.45%852.69M | 40.72%818.58M | 41.82%839.46M | 59.49%868.21M | -23.26%458.08M | 151.32%832.3M | -12.79%581.71M | -23.27%591.92M |
| Selling and administrative expenses | ---- | 3.20%481.03M | ---- | ---- | ---- | ---- | -22.62%466.09M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | 21.87%92.85M | ---- | ---- | ---- | ---- | -0.62%76.19M | ---- | ---- | ---- |
| -General and administrative expense | ---- | -0.44%388.18M | ---- | ---- | ---- | ---- | -25.83%389.9M | ---- | ---- | ---- |
| Other operating expenses | -4.45%842.93M | -100.00%-57K | -3.49%856.24M | 22.49%821.93M | 38.60%839.46M | 59.53%882.17M | --2.72B | --887.21M | 0.60%671.04M | -21.48%605.68M |
| Total other operating income | -82.44%2.45M | -23.08%6.16M | -93.53%3.55M | -96.25%3.35M | ---- | 62.24%13.96M | 48.66%8.01M | --54.91M | --89.33M | --13.76M |
| Operating profit | 143.74%43.1M | 111.45%22.07M | 2,463.01%36.93M | -78.85%11.67M | 206.28%44.2M | 134.72%17.68M | 63.81%-192.76M | 101.52%1.44M | 140.45%55.17M | 72.89%-41.59M |
| Net non-operating interest income expense | -747.81%-7.7M | 122.78%6.31M | 252.87%12.35M | -1,029.06%-7.67M | 407.75%397K | 187.10%1.19M | -38.58%2.83M | 5,830.51%3.5M | 35.19%826K | -108.37%-129K |
| Non-operating interest income | -48.07%1.16M | 123.25%28.52M | 321.42%21.51M | -26.11%1.96M | -15.64%2.58M | 13.17%2.23M | -26.41%12.77M | 19.84%5.1M | -40.37%2.65M | -29.66%3.06M |
| Non-operating interest expense | 752.79%8.85M | 123.39%22.21M | 470.95%9.16M | 429.07%9.63M | -31.51%2.18M | -68.84%1.04M | -22.01%9.94M | -61.80%1.6M | -52.43%1.82M | 13.62%3.19M |
| Net investment income | -63.24%2.18M | 268.67%28.97M | 100.88%112K | -119.29%-4.57M | -3.39M | 5.93M | -5.84%7.86M | -12.77M | 23.7M | |
| Gain/Loss on financial instruments designated as cash flow hedges | 0 | -603K | -533K | 752K | 245K | 311K | ||||
| Gain/Loss on derecognition of available-for-sale financial assets | -39.51%2.49M | -29.53%12.77M | -257.20%-9.01M | -65.70%1.41M | 4.24M | 4.12M | 208.65%18.12M | 5.73M | 4.11M | |
| Income from associates and other participating interests | 246.84%1.92M | -192.62%-1.6M | -206.44%-1.16M | -181.47%-2.08M | 181.08%1.09M | 196.01%553K | 129.79%1.72M | 141.16%1.09M | 193.46%2.56M | -334.84%-1.35M |
| Special income /charges | -75.91%-2.42M | -49.71%52.5M | -90.42%3.33M | -48.07%27.35M | 1.68M | -1.37M | 126.49%104.4M | 34.72M | 52.67M | |
| Less:Impairment of capital assets | 12.38%2.55M | 114.89%21.95M | 231.33%15.79M | 41.57%2.37M | --1.52M | --2.27M | -94.82%10.21M | --4.77M | --1.67M | ---- |
| Less:Other special charges | 85.04%-134K | 49.71%-52.5M | 51.59%-19.11M | 45.32%-29.72M | ---3.2M | ---896K | -809.69%-104.4M | ---39.48M | ---54.34M | ---- |
| Less:Negative goodwill immediately recognized | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non-operating income /expenses | 16.79%5.63M | 5.60%27.18M | 51.12%5.28M | -41.32%5.09M | 8.36M | 4.82M | 95.01%25.74M | 3.49M | 8.68M | |
| Income before tax | 132.72%45.2M | 572.86%148.2M | 693.61%47.83M | -46.73%31.19M | 229.99%55.98M | 136.74%19.42M | 96.52%-31.34M | 101.30%6.03M | 142.27%58.55M | 70.49%-43.06M |
| Income tax | 138.15%6.37M | 355.34%25.35M | 557.55%12.24M | -1.70%-3.23M | 605.65%14.85M | 147.11%2.68M | 33.21%-9.93M | 115.89%1.86M | 82.55%-3.17M | -132.48%-2.94M |
| Net income | 131.85%38.83M | 673.73%122.85M | 754.39%35.59M | -44.24%34.42M | 202.49%41.13M | 135.49%16.75M | 97.58%-21.41M | 100.92%4.17M | 151.29%61.73M | 74.11%-40.13M |
| Net income continuous operations | 131.85%38.83M | 673.73%122.85M | 754.39%35.59M | -44.24%34.42M | 202.49%41.13M | 135.49%16.75M | 97.58%-21.41M | 100.92%4.17M | 151.29%61.73M | 74.11%-40.13M |
| Noncontrolling interests | 150.84%242K | -77.91%-5.6M | -263.53%-2.97M | 52.97%-325K | 4.38%-524K | 56.33%-476K | 54.68%-3.15M | 68.89%-817K | 54.33%-691K | 69.52%-548K |
| Net income attributable to the company | 124.03%38.58M | 803.18%128.44M | 673.91%38.56M | -44.33%34.75M | 205.24%41.65M | 137.37%17.22M | 97.92%-18.27M | 101.11%4.98M | 152.52%62.42M | 74.16%-39.58M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | -50.41%23.11M | 0 | 0 | -2.19%11.37M | 1.09%11.75M | 0.00%46.61M | -1.08%11.62M | -0.01%11.75M | 1.11%11.62M |
| Net income attributable to common stockholders | 604.84%38.58M | 262.36%105.33M | 680.96%38.56M | -31.43%34.75M | 159.15%30.28M | 109.49%5.47M | 92.99%-64.88M | 98.56%-6.64M | 138.80%50.67M | 68.91%-51.2M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 585.71%0.0048 | 261.73%0.0131 | 700.00%0.0048 | -31.75%0.0043 | 159.38%0.0038 | 109.72%0.0007 | 92.99%-0.0081 | 98.61%-0.0008 | 138.65%0.0063 | 68.93%-0.0064 |
| Diluted earnings per share | 585.71%0.0048 | 261.73%0.0131 | 700.00%0.0048 | -31.75%0.0043 | 159.38%0.0038 | 109.72%0.0007 | 92.99%-0.0081 | 98.61%-0.0008 | 138.65%0.0063 | 68.93%-0.0064 |
| Dividend per share | 0.0048 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR | MYR |